默沙东(MRK)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MRK 默沙东

盘前交易 01-13 04:09:09 EST

109.19

-1.34

-1.21%

最高111.46	最低108.78	成交量1,067万
今开110.97	昨收110.53	日振幅2.42%
总市值2,710亿	流通市值2,710亿	总股本24.82亿
成交额11.69亿	换手率0.43%	流通股本24.82亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"MRK","market":"US","secType":"STK","nameCN":"默沙东","latestPrice":109.19,"timestamp":1768251600000,"preClose":110.53,"halted":0,"volume":10671910,"delay":0,"floatShares":2482022536,"shares":2482022536,"eps":7.555931,"marketStatus":"盘前交易","change":-1.34,"latestTime":"01-13 04:09:09 EST","open":110.97,"high":111.46,"low":108.78,"amount":1169334305.1493,"amplitude":0.024247,"askPrice":109.92,"askSize":100,"bidPrice":107.08,"bidSize":25,"shortable":3,"etf":0,"ttmEps":7.555931,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768314600000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":-745790400000,"exchange":"NYSE","adjPreClose":109.19,"dividendRate":0.0297,"postHourTrading":{"tag":"盘后","latestPrice":109.4,"preClose":109.19,"latestTime":"19:59 EST","volume":883106,"amount":96426200.8496,"timestamp":1768265972044},"volumeRatio":0.6840479731366658,"impliedVol":0.2913,"impliedVolPercentile":0.184},"requestUrl":"/m/hq/s/MRK","defaultTab":"news","newsList":[{"id":"2603570148","title":"默沙东预计2030年代中期新业务营收将达700亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603570148","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603570148?lang=zh_cn&edition=full","pubTime":"2026-01-13 14:29","pubTimestamp":1768285740,"startTime":"0","endTime":"0","summary":"默沙东周一表示，该公司已上调对新增长动力的预期，预计到本世纪30年代中期，这些新业务的营收将达到700亿美元。该公司正在加速推出更多药物，以应对其畅销癌症治疗药物Keytruda即将面临的竞争。\n　　该公司目前预计，心脏代谢和呼吸治疗药物将产生约200亿美元的销售额，高于此前预计的150亿美元，而传染病药物预计将贡献约150亿美元，高于此前估计的50亿美元。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：于健 SF069","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-01-13/doc-inhhcxix4908004.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1585245621.USD","LU1069347547.HKD","LU2361044949.HKD","LU1974910355.USD","IE0009355771.USD","LU0965509283.SGD","LU1057294990.SGD","IE00BJT1NW94.SGD","LU0861579265.USD","LU1201861249.SGD","SG9999014567.USD","BK4533","LU1037948541.HKD","IE00BLSP4452.SGD","LU2324357040.USD","LU0477156953.USD","LU2023250843.SGD","LU0238689110.USD","LU1934455194.USD","LU1037948897.HKD","LU0265550359.USD","LU1929549753.HKD","LU1699723380.USD","IE0002141913.USD","LU2361045086.USD","SG9999001440.SGD","LU0070302665.USD","LU1116320737.USD","IE00BLSP4239.USD","LU0965509010.AUD","LU0965508806.USD","IE00B1BXHZ80.USD","LU1989772840.SGD","LU1066051811.HKD","LU2089984988.USD","LU0203347892.USD","BK4585","LU2023250504.SGD","LU0203345920.USD","LU1066053197.SGD","LU2125154935.USD","LU2112291526.USD","LU2361044865.SGD","LU1035773651.USD","LU0234572021.USD","LU0122379950.USD","LU0320765646.SGD","LU0648001328.SGD","LU0208291251.USD","LU2461242641.AUD","IE000M9KFDE8.USD","LU0106261372.USD","LU0058720904.USD","IE00BSNM7G36.USD","LU0130102774.USD","LU1430594728.SGD","LU1917777945.USD","BK4534","IE00B2B36J28.USD","BK4559","IE00BJJMRZ35.SGD","LU1571399168.USD","LU2468319806.SGD","LU1934455863.HKD","IE00B4R5TH58.HKD","LU0266013472.USD","SG9999001176.SGD","LU1066051225.USD","LU1162221912.USD","LU0130517989.USD","LU0098860793.USD","LU1291159041.SGD","BK4516","LU0211331839.USD","LU0289739699.SGD","SG9999015358.SGD","MRK","LU1941712264.USD","IE00BFTCPJ56.SGD","SG9999001176.USD","LU2125154778.USD","BK4550","SG9999013999.USD","LU1061106388.HKD","LU1983299246.USD","LU1989772923.USD","SG9999002224.SGD","LU0320765489.SGD","SG9999015341.SGD","LU1941712348.USD","SG9999014542.SGD","LU2360032135.SGD","LU0985320562.USD","LU1989771016.USD","IE00BBT3K403.USD","LU0980610538.SGD","SG9999014575.USD","BK4007","LU1093756168.USD","BK4588","LU0965509101.SGD","IE00BN8TJ469.HKD","LU2106854487.HKD","LU0006306889.USD","SG9999014559.SGD","LU1116320901.HKD","SGXZ57979304.SGD","LU1093756325.SGD","SG9999002232.USD","LU1934455277.USD","LU1066051498.USD","LU0265550946.USD","LU1023059063.AUD"],"gpt_icon":0},{"id":"1101957236","title":"“K药”专利倒计时|默沙东亮出百亿美元“肌肉”! 欲在创新药领域掀起收购巨浪","url":"https://stock-news.laohu8.com/highlight/detail?id=1101957236","media":"智通财经","labels":["corporation","merge"],"top":1,"itemType":null,"share":"https://www.laohu8.com/m/news/1101957236?lang=zh_cn&edition=full","pubTime":"2026-01-13 13:19","pubTimestamp":1768281556,"startTime":"0","endTime":"0","summary":"在外界纷纷猜测默沙东正就收购抗癌类药物研发企业Revolution Medicines进行谈判之际，上述言论无疑引发市场重点关注。“药王”Keytruda 2028年到期，默沙东的“收购之手”已经迫不及待对于默沙东销售额与利润前景而言，Keytruda 2028年专利压力可谓是“时间表驱动”的补缺口需求。而默沙东前不久以约100亿美元收购 Verona Pharma、将COPD维持治疗药物纳入版图，是“呼吸疾病赛道可用资本加速买入”的最直接例证。","market":"us","thumbnail":"https://static.tigerbbs.com/8063c97727cb21de0867e6829ff807e3","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/8063c97727cb21de0867e6829ff807e3"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/content/detail/1392081.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"“K药”专利倒计时|默沙东亮出百亿美元“肌肉”! 欲在创新药领域掀起收购巨浪","news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["MRK"],"gpt_icon":0},{"id":"2602960582","title":"罗氏从5.7亿美元从宜联生物引进B7H3 ADC，加码SCLC布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2602960582","media":"Minhua笔记","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602960582?lang=zh_cn&edition=full","pubTime":"2026-01-10 16:41","pubTimestamp":1768034502,"startTime":"0","endTime":"0","summary":"1月8日，罗氏宣布与宜联生物达成一项最高达5.7亿美元的授权许可协议，获得后者靶向B7H3的ADC tambotatug pelitecan中国以外地区的全球独家权益。双方于2024年初首次合作，达成一项价值近10亿美元的协议，共同开发宜联生物的ADC药物YL211，该药物靶向c-Met，用于治疗实体瘤。据宜联生物称，初步数据显示，该药物在SCLC二线治疗中展现出令人鼓舞的客观缓解率和生存获益。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260110164641a4b35e86&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260110164641a4b35e86&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRK","BK1583","LU2242644610.SGD","LU2328871848.SGD","LU0455707207.USD","LU2097828474.EUR","LU0502904849.HKD","LU2097828805.USD","HK0000165453.HKD","LU1969619763.USD","LU2097828557.USD","01801","LU2097828631.EUR","LU2097828714.EUR","LU2488822045.USD","BK1589","BK1161"],"gpt_icon":0},{"id":"2602037039","title":"默沙东关注RVMD 艾伯维否认兴趣","url":"https://stock-news.laohu8.com/highlight/detail?id=2602037039","media":"环球市场播报","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602037039?lang=zh_cn&edition=full","pubTime":"2026-01-10 00:09","pubTimestamp":1767974940,"startTime":"0","endTime":"0","summary":"默沙东（MRK）周五早盘下跌0.3%。据英国《金融时报》报道，正洽谈以潜在数十亿美元交易收购Revolution Medicines（RVMD），此前一天艾伯维（ABBV）表示未与该生物技术公司进行讨论。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：张俊 SF065","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c2d46f3176d31be87e42705d65675998","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-01-10/doc-inhftucf5577600.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0203345920.USD","MRK","LU2461242641.AUD","LU1035773651.USD","SG9999014542.SGD","IE00B2B36J28.USD","LU1934455194.USD","LU0265550946.USD","LU1989772840.SGD","LU1066051811.HKD","BK4534","LU1917777945.USD","LU0234572021.USD","LU0122379950.USD","LU0070302665.USD","LU2125154778.USD","BK4585","LU2468319806.SGD","SG9999013999.USD","LU1023059063.AUD","LU0265550359.USD","LU1093756168.USD","SG9999002232.USD","LU1093756325.SGD","SG9999014575.USD","LU1941712264.USD","LU0106261372.USD","LU1066051225.USD","LU0965509283.SGD","LU1929549753.HKD","LU0320765646.SGD","LU0965509010.AUD","LU2023250843.SGD","LU1057294990.SGD","LU1974910355.USD","LU0648001328.SGD","SG9999001176.USD","SG9999015358.SGD","BK4588","LU1430594728.SGD","IE00B4R5TH58.HKD","LU0985320562.USD","LU1989771016.USD","LU0238689110.USD","LU1934455863.HKD","LU0211331839.USD","LU1201861249.SGD","LU2324357040.USD","LU1116320737.USD","ABBV","LU2106854487.HKD","BK4559","SG9999001176.SGD","LU0477156953.USD","LU1983299246.USD","LU0289739699.SGD","IE0002141913.USD","IE00BFTCPJ56.SGD","LU2360032135.SGD","BK4516","BK4550","LU0006306889.USD","LU1291159041.SGD","BK4007","LU2112291526.USD","SG9999014567.USD","LU2089984988.USD","RVMD","IE00BBT3K403.USD","LU1585245621.USD","LU0203347892.USD","LU1941712348.USD","LU2125154935.USD","LU1571399168.USD","IE00BJT1NW94.SGD","LU1061106388.HKD","LU1037948897.HKD","IE00B1BXHZ80.USD","IE00BN8TJ469.HKD","IE000M9KFDE8.USD","LU0208291251.USD","LU2023250504.SGD","LU0965508806.USD","LU2361044865.SGD","LU0965509101.SGD","LU2361044949.HKD","IE0009355771.USD","LU0320765489.SGD","IE00BSNM7G36.USD","LU1699723380.USD","LU0098860793.USD","LU1162221912.USD","LU0130517989.USD","LU0058720904.USD","LU1066051498.USD","IE00BJJMRZ35.SGD","LU1037948541.HKD","BK4533","SG9999014559.SGD","BK4139","LU1066053197.SGD","LU0980610538.SGD","LU1989772923.USD","SG9999001440.SGD","LU0861579265.USD","LU1116320901.HKD","LU1069347547.HKD","LU1934455277.USD","IE00BLSP4239.USD","SGXZ57979304.SGD","LU2361045086.USD","LU0266013472.USD","SG9999002224.SGD","SG9999015341.SGD","IE00BLSP4452.SGD","LU0130102774.USD"],"gpt_icon":0},{"id":"2602379717","title":"不再迷惘的制药商：2025年并购额暴涨124%，巨头狂扫创新药资产","url":"https://stock-news.laohu8.com/highlight/detail?id=2602379717","media":"智通财经网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602379717?lang=zh_cn&edition=full","pubTime":"2026-01-09 21:50","pubTimestamp":1767966634,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，下周，制药商们将赴旧金山出席摩根大通医疗健康年会，心态较2025年显著放松。多起交易消息公布后，买方股价应声上涨，表明投资者希望它们继续出手。部分交易人士预计，2026年还将好于去年。数据显示，2025年制药商共达成1300亿美元交易，较上年增长124%。在FDA政策走向彻底明朗前，业内普遍预期部分制药商将对重大并购交易采取更为审慎的态度。","market":"sg","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1391216.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["MRK","BMY","PFE"],"gpt_icon":0},{"id":"2602326185","title":"花旗上调默沙东目标价至110美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602326185","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602326185?lang=zh_cn&edition=full","pubTime":"2026-01-09 16:58","pubTimestamp":1767949081,"startTime":"0","endTime":"0","summary":"花旗将默沙东的目标价从95美元上调至110美元，维持“中性”评级。(格隆汇)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260109/31929720.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["IE0009355771.USD","IE00BLSP4452.SGD","LU0965509010.AUD","LU1035773651.USD","LU1929549753.HKD","LU1941712264.USD","LU0130517989.USD","LU2324357040.USD","LU1066053197.SGD","SG9999001176.USD","LU0170899867.USD","LU0130102774.USD","BK4566","LU0477156953.USD","LU0861579265.USD","SGXZ57979304.SGD","LU2023250504.SGD","SG9999014559.SGD","BK4516","LU0320765489.SGD","LU0648001328.SGD","LU1934455277.USD","LU2236285917.USD","LU1989772923.USD","LU1974910355.USD","LU0128525689.USD","LU1571399168.USD","LU1093756168.USD","LU1037948541.HKD","LU1934455863.HKD","LU0203345920.USD","LU1934455194.USD","LU0208291251.USD","LU1162221912.USD","MRK","LU0106831901.USD","LU0006306889.USD","IE00BJJMRZ35.SGD","IE00BBT3K403.USD","LU1585245621.USD","LU0070302665.USD","LU1989772840.SGD","LU0203347892.USD","LU0289739699.SGD","LU0106261372.USD","LU0162691827.USD","LU2360032135.SGD","LU0098860793.USD","LU1116320737.USD","LU1699723380.USD","BK4207","LU2023250843.SGD","SG9999015341.SGD","LU0265550946.USD","LU1116320901.HKD","SG9999002224.SGD","LU0266013472.USD","IE00BSNM7G36.USD","LU2112291526.USD","LU2461242641.AUD","LU2468319806.SGD","LU1291159041.SGD","LU0122379950.USD","LU1061106388.HKD","LU1244550577.SGD","LU0965509283.SGD","LU1066051498.USD","LU1201861249.SGD","BK4588","LU0058720904.USD","LU1023059063.AUD","BK4534","LU1066051811.HKD","LU1668664300.SGD","LU0211331839.USD","IE000M9KFDE8.USD","LU2361044949.HKD","LU0052756011.USD","LU0980610538.SGD","LU1989771016.USD","LU1267930227.SGD","LU1941712348.USD","LU1066051225.USD","LU0320765646.SGD","BK4559","LU1983299246.USD","LU2106854487.HKD","LU2089984988.USD","LU1917777945.USD","IE0002141913.USD","LU0310800965.SGD","IE00BFTCPJ56.SGD","LU2125154778.USD","LU1244550221.USD","SG9999002232.USD","LU0965508806.USD","IE00BLSP4239.USD","LU0265550359.USD","LU2361045086.USD","SG9999014575.USD","SG9999001176.SGD","IE00B1BXHZ80.USD","LU1430594728.SGD","LU0985320562.USD","BK4007","LU0238689110.USD","IE00B4R5TH58.HKD","IE00BN8TJ469.HKD","LU2125154935.USD","IE00B2B36J28.USD","LU1037948897.HKD","LU2456880835.USD","LU0965509101.SGD","LU2361044865.SGD","LU2462157665.USD","BK4550","LU1791807156.HKD","LU0072461881.USD","LU2417539215.USD","LU1057294990.SGD","SG9999013999.USD","SG9999014542.SGD","LU1366192091.USD","SG9999001440.SGD","BK4533","SG9999014567.USD","LU1069347547.HKD","SG9999015358.SGD","IE00BJT1NW94.SGD","BK4585","LU0234572021.USD","BK4504","LU1093756325.SGD","LU1244550494.USD"],"gpt_icon":0},{"id":"2602006340","title":"千亿美元“专利悬崖”逼近！美股制药巨头瞄准收购新药，中小盘生物科技股迎来“超级溢价”投资盛宴？","url":"https://stock-news.laohu8.com/highlight/detail?id=2602006340","media":"智通财经","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602006340?lang=zh_cn&edition=full","pubTime":"2026-01-09 16:00","pubTimestamp":1767945631,"startTime":"0","endTime":"0","summary":"而多种因素共同促成了生物科技并购的爆发式增长。一些全球最畅销的药物正面临在关键地区失去专利保护的风险，这被业内称为“专利悬崖”。据计算，到2032年，畅销品牌专利保护期的丧失将造成至少1739亿美元的年销售额损失。生物科技板块近几年经历繁荣、衰退，然后又是繁荣新冠疫情期间，生物科技行业迅速成为投资者的热门之选。Loren表示，一系列利好数据也推高了生物科技股的估值。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1390856.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"美股制药巨头瞄准收购新药，中小盘生物科技股迎来“超级溢价”投资盛宴？","news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["MRK","BMY","GSK","NVO","AZN","NVS","PFE","LLY"],"gpt_icon":1},{"id":"2602341517","title":"Wolfe Research：默沙东(MRK.US)应对Keytruda“专利悬崖”有方 上调评级至“跑赢大盘”","url":"https://stock-news.laohu8.com/highlight/detail?id=2602341517","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602341517?lang=zh_cn&edition=full","pubTime":"2026-01-09 13:34","pubTimestamp":1767936875,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，投行Wolfe Research将其对默沙东的股票评级由“与同行表现一致”上调至“跑赢大盘”，目标价为135美元。该行分析师Alexandria Hammond表示，默沙东在应对其重磅抗癌药Keytruda静脉注射版本即将失去市场独占权方面处于有利位置。她因此将Keytruda产品线在2030年的收入预测上调至较市场一致预期高出60亿美元。而与Revolution Medicines的交易可能使默沙东获得其实验性药物Daraxonrasib。在关节炎重磅药物Humira遭遇专利悬崖后，这两款产品已成为艾伯维免疫与炎症产品组合的主导力量。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1390795.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1941712348.USD","BK4588","LU1066051811.HKD","LU2360032135.SGD","LU1093756168.USD","LU2125154935.USD","LU2125154778.USD","LU1066053197.SGD","LU1934455194.USD","LU2089984988.USD","LU0265550946.USD","LU2023250504.SGD","SG9999013999.USD","LU1116320737.USD","SG9999015358.SGD","MRK","LU0266013472.USD","LU1037948541.HKD","LU2106854487.HKD","LU1061106388.HKD","LU1066051498.USD","LU2361045086.USD","LU1934455863.HKD","LU0058720904.USD","SG9999015341.SGD","LU0648001328.SGD","LU1162221912.USD","LU2112291526.USD","LU1917777945.USD","LU0861579265.USD","LU0965509283.SGD","IE0009355771.USD","BK4585","IE00BBT3K403.USD","SG9999001176.SGD","LU1974910355.USD","LU0122379950.USD","LU1057294990.SGD","LU0106261372.USD","LU1983299246.USD","LU1934455277.USD","IE00B4R5TH58.HKD","SG9999014567.USD","LU1989771016.USD","IE00BLSP4239.USD","LU0265550359.USD","SG9999014542.SGD","BK4007","LU1066051225.USD","IE000M9KFDE8.USD","LU0289739699.SGD","LU0130517989.USD","LU0980610538.SGD","BK4550","LU1585245621.USD","IE00BSNM7G36.USD","LU1291159041.SGD","IE00BJT1NW94.SGD","LU0203347892.USD","SG9999014559.SGD","LU1069347547.HKD","LU1989772840.SGD","LU2324357040.USD","LU1037948897.HKD","SGXZ57979304.SGD","LU0477156953.USD","LU2461242641.AUD","LU0238689110.USD","IE00BFTCPJ56.SGD","LU2468319806.SGD","BK4534","LU1023059063.AUD","LU1571399168.USD","LU1941712264.USD","LU0070302665.USD","IE00BJJMRZ35.SGD","LU1989772923.USD","LU0098860793.USD","LU2023250843.SGD","SG9999002232.USD","IE00B1BXHZ80.USD","LU0320765646.SGD","LU0320765489.SGD","LU1699723380.USD","SG9999001176.USD","LU0234572021.USD","IE00B2B36J28.USD","LU0130102774.USD","LU1430594728.SGD","LU0965508806.USD","LU1929549753.HKD","LU2361044949.HKD","IE00BLSP4452.SGD","LU0985320562.USD","LU1035773651.USD","LU0965509010.AUD","LU0211331839.USD","LU1116320901.HKD","LU2361044865.SGD","SG9999002224.SGD","LU1201861249.SGD","LU0203345920.USD","IE00BN8TJ469.HKD","LU0965509101.SGD","SG9999001440.SGD","BK4533","SG9999014575.USD","LU0006306889.USD","BK4516","LU1093756325.SGD","IE0002141913.USD","BK4559","LU0208291251.USD"],"gpt_icon":0},{"id":"2602129793","title":"传获默沙东洽谈收购癌症药物开发商Revolution，交易价格或达320亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602129793","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602129793?lang=zh_cn&edition=full","pubTime":"2026-01-09 11:23","pubTimestamp":1767929007,"startTime":"0","endTime":"0","summary":"受此消息提振，截至发稿，Revolution Medicines周四美股盘后大涨超15%。不过，艾伯维随后回应称，该公司没有就收购Revolution Medicines进行谈判。Revolution Medicines在去年12月宣布，RASolute304临床试验已完成首例患者入组。根据行业研究的分析，Revolution Medicines的药物研发管线使其成为极具吸引力的收购对象。默沙东的重磅抗癌药物Keytruda将在本十年末失去专利。而与Revolution Medicines的交易可能使默沙东获得其实验性药物Daraxonrasib。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c2d46f3176d31be87e42705d65675998","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1390702.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"传获默沙东洽谈收购癌症药物开发商Revolution，交易价格或达320亿美元","news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["RVMD","MRK"],"gpt_icon":0},{"id":"2602831784","title":"美股异动｜Revolution Medicines夜盘涨超13%，传获默沙东以至多320亿美元报价洽购","url":"https://stock-news.laohu8.com/highlight/detail?id=2602831784","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602831784?lang=zh_cn&edition=full","pubTime":"2026-01-09 09:22","pubTimestamp":1767921721,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c2d46f3176d31be87e42705d65675998","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU1093756168.USD","LU1989771016.USD","SG9999002224.SGD","LU1201861249.SGD","SG9999014542.SGD","LU1929549753.HKD","LU1571399168.USD","IE00BFTCPJ56.SGD","LU0058720904.USD","LU0980610538.SGD","LU1093756325.SGD","LU0965508806.USD","LU2360032135.SGD","LU0130102774.USD","LU1066053197.SGD","LU1989772840.SGD","IE00BLSP4239.USD","LU0130517989.USD","LU0234572021.USD","LU1934455863.HKD","LU1037948897.HKD","LU1974910355.USD","LU0006306889.USD","LU2361044865.SGD","LU0861579265.USD","BK4007","SG9999001176.USD","LU2125154778.USD","LU2468319806.SGD","RVMD","LU2361045086.USD","MRK","LU0289739699.SGD","IE000M9KFDE8.USD","LU0070302665.USD","LU2361044949.HKD","LU0648001328.SGD","LU1023059063.AUD","LU0477156953.USD","SGXZ57979304.SGD","LU0965509010.AUD","LU2125154935.USD","BK4516","LU1057294990.SGD","LU0208291251.USD","LU1066051498.USD","LU1066051811.HKD","SG9999001440.SGD","BK4533","LU1989772923.USD"],"gpt_icon":0},{"id":"2602732316","title":"默沙东据悉洽购抗癌药开发商Revolution Medicines，交易价格或超300亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602732316","media":"环球市场播报","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602732316?lang=zh_cn&edition=full","pubTime":"2026-01-09 07:09","pubTimestamp":1767913740,"startTime":"0","endTime":"0","summary":"据知情人士称，美国制药巨头默沙东正就收购抗癌药物开发商Revolution Medicines进行谈判，交易金额为可能在280亿至320亿美元之间。　　受此消息推动，Revolution的股价在盘后交易中上涨了近16%。　　知情人士称，默沙东一直在寻求收购Revolution Medicines，但交易尚未敲定，并补充称，达成交易至少需要数周时间。　　瑞穗分析师估计，到2035年，Revolution的RAS抑制剂产品组合在全球的潜在销售额将超过100亿美元。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c2d46f3176d31be87e42705d65675998","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-01-09/doc-inhfrztx3219551.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU2106854487.HKD","LU1116320737.USD","SG9999015341.SGD","BK4007","BK4588","IE00BLSP4239.USD","LU1093756325.SGD","LU0648001328.SGD","LU0211331839.USD","LU1941712264.USD","LU1057294990.SGD","IE00BBT3K403.USD","SG9999014575.USD","LU1201861249.SGD","IE0009355771.USD","LU1571399168.USD","LU2023250504.SGD","LU2089984988.USD","LU1035773651.USD","LU1061106388.HKD","LU2468319806.SGD","LU1023059063.AUD","LU0985320562.USD","IE00B1BXHZ80.USD","LU0098860793.USD","LU2361044865.SGD","LU0289739699.SGD","LU0861579265.USD","LU1989772923.USD","LU2361044949.HKD","LU1430594728.SGD","LU2360032135.SGD","IE00BJT1NW94.SGD","LU1093756168.USD","LU0265550359.USD","RVMD","SG9999001176.USD","LU0130517989.USD","IE000M9KFDE8.USD","LU2324357040.USD","IE00BN8TJ469.HKD","LU2461242641.AUD","LU0265550946.USD","LU0203347892.USD","LU2125154935.USD","IE00BLSP4452.SGD","LU0203345920.USD","LU2125154778.USD","SG9999002232.USD","IE00B2B36J28.USD","SG9999014559.SGD","LU1066053197.SGD","BK4533","LU1699723380.USD","LU2361045086.USD","LU0965508806.USD","SG9999002224.SGD","BK4139","BK4550","LU0130102774.USD","IE00BFTCPJ56.SGD","LU1983299246.USD","LU1069347547.HKD","LU0965509010.AUD","LU1291159041.SGD","SG9999001176.SGD","SG9999013999.USD","LU0070302665.USD","LU0238689110.USD","SGXZ57979304.SGD","LU1934455863.HKD","IE00BJJMRZ35.SGD","LU0058720904.USD","BK4585","LU0122379950.USD","LU1929549753.HKD","LU0965509101.SGD","LU0208291251.USD","LU0106261372.USD","SG9999014542.SGD","LU1941712348.USD","LU1974910355.USD","LU2023250843.SGD","BK4559","LU2112291526.USD","LU1162221912.USD","SG9999001440.SGD","IE0002141913.USD","LU0234572021.USD","LU1066051498.USD","LU1934455277.USD","LU1116320901.HKD","LU1917777945.USD","LU1989772840.SGD","LU0965509283.SGD","BK4516","LU1037948897.HKD","LU1037948541.HKD","LU1585245621.USD","SG9999015358.SGD","BK4534","LU0320765646.SGD","SG9999014567.USD","LU0006306889.USD","LU0477156953.USD","LU1989771016.USD","LU0320765489.SGD","MRK","LU1934455194.USD","LU0980610538.SGD","LU1066051811.HKD","IE00B4R5TH58.HKD","LU0266013472.USD","LU1066051225.USD","IE00BSNM7G36.USD"],"gpt_icon":0},{"id":"1154509757","title":"默沙东呼吁：需基于明确循证建议，保障儿童与青少年获得可靠可预防疾病防护","url":"https://stock-news.laohu8.com/highlight/detail?id=1154509757","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154509757?lang=zh_cn&edition=full","pubTime":"2026-01-09 06:05","pubTimestamp":1767909958,"startTime":"0","endTime":"0","summary":"为切实守护儿童及青少年健康，默沙东强调当前亟需建立清晰且以实证为基础的指导方案。此类科学建议将有效确保年轻群体获得针对可预防疾病的持久免疫保护，避免疫苗可控疾病对其成长发育造成潜在威胁。通过系统化的接种策略与权威指引，能够构建更完善的公共卫生防线，为下一代健康成长筑牢基石。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","LU0238689110.USD","LU1941712264.USD","LU0265550946.USD","SG9999002224.SGD","LU1023059063.AUD","LU0130102774.USD","BK4588","LU0234572021.USD","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","LU1974910355.USD","LU0122379950.USD","LU1069347547.HKD","LU2106854487.HKD","LU0320765646.SGD","LU2324357040.USD","LU1116320901.HKD","MRK","LU1983299246.USD","LU1066053197.SGD","BK4550","BK4516","LU2361044865.SGD","IE00BSNM7G36.USD","SG9999015341.SGD","BK4007","LU0289739699.SGD","LU0208291251.USD","LU0965509010.AUD","LU0861579265.USD","LU2089984988.USD","LU1989772923.USD","IE00B2B36J28.USD","BK4585","SG9999014575.USD","LU1989771016.USD","LU0106261372.USD","LU0477156953.USD","LU2361045086.USD","LU0965508806.USD","IE0002141913.USD","LU1571399168.USD","LU2112291526.USD","LU1093756325.SGD","IE00BJT1NW94.SGD","LU0980610538.SGD","LU1934455194.USD","LU2023250843.SGD","LU1917777945.USD","LU0203345920.USD","SG9999002232.USD","LU1934455863.HKD","LU0320765489.SGD","IE0009355771.USD","LU0648001328.SGD","LU1934455277.USD","LU1162221912.USD","LU1201861249.SGD","LU1116320737.USD","LU0130517989.USD","LU2360032135.SGD","SG9999001440.SGD","LU2125154778.USD","SG9999001176.USD","IE00BJJMRZ35.SGD","LU1035773651.USD","LU2361044949.HKD","LU1066051811.HKD","LU1066051498.USD","LU0985320562.USD","LU2461242641.AUD","LU1989772840.SGD","LU1585245621.USD","IE00BBT3K403.USD","SGXZ57979304.SGD","LU2023250504.SGD","LU0965509283.SGD","SG9999013999.USD","BK4534","LU1037948541.HKD","LU1037948897.HKD","LU1061106388.HKD","SG9999015358.SGD","SG9999014542.SGD","LU1057294990.SGD","SG9999001176.SGD","LU1093756168.USD","LU0070302665.USD","LU1291159041.SGD","LU0965509101.SGD","BK4559","LU0098860793.USD","LU0211331839.USD","BK4533","SG9999014567.USD","LU1430594728.SGD","LU1941712348.USD","LU2125154935.USD","LU2468319806.SGD","LU0265550359.USD","IE00BLSP4452.SGD","LU1699723380.USD","LU0006306889.USD","IE00BN8TJ469.HKD","SG9999014559.SGD","LU1066051225.USD","LU1929549753.HKD","LU0203347892.USD","IE00B1BXHZ80.USD","IE00BLSP4239.USD","IE000M9KFDE8.USD","LU0266013472.USD"],"gpt_icon":0},{"id":"1180086398","title":"美国卫生与公众服务部调整免疫计划之际 默沙东强调决策需以全面数据为基石","url":"https://stock-news.laohu8.com/highlight/detail?id=1180086398","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1180086398?lang=zh_cn&edition=full","pubTime":"2026-01-09 06:02","pubTimestamp":1767909769,"startTime":"0","endTime":"0","summary":"在美国卫生与公众服务部（HHS）对免疫计划进行修订的关键时刻，默沙东（Merck & Co.）指出，任何政策调整都必须建立在详实、全面的科学数据基础之上。\n这一表态凸显了数据驱动决策在公共卫生领域的重要性。随着疫苗接种策略的演变，确保每一处修改都经过充分验证，才能有效保障公众健康并维持医疗体系的科学严谨性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1934455277.USD","MRK","IE00BBT3K403.USD","LU1066051225.USD","SGXZ57979304.SGD","LU2089984988.USD","SG9999001176.SGD","SG9999014559.SGD","BK4007","LU1116320737.USD","LU1066051498.USD","IE00B2B36J28.USD","SG9999001176.USD","LU1162221912.USD","LU1023059063.AUD","BK4534","LU0985320562.USD","IE00B4R5TH58.HKD","LU2125154935.USD","IE00BLSP4452.SGD","IE00BN8TJ469.HKD","IE00BSNM7G36.USD","LU1057294990.SGD","LU2361044949.HKD","LU1571399168.USD","BK4550","LU2360032135.SGD","LU1934455194.USD","LU0477156953.USD","LU2125154778.USD","LU0006306889.USD","LU1989772923.USD","IE00BJT1NW94.SGD","LU0070302665.USD","LU1061106388.HKD","LU0106261372.USD","LU1974910355.USD","IE000M9KFDE8.USD","LU1934455863.HKD","LU1917777945.USD","LU2324357040.USD","SG9999015341.SGD","LU0208291251.USD","LU1037948897.HKD","LU0203345920.USD","LU2023250504.SGD","LU1066053197.SGD","SG9999014542.SGD","LU0265550946.USD","LU0965509283.SGD","LU2106854487.HKD","LU1989771016.USD","BK4585","LU2461242641.AUD","BK4516","SG9999002224.SGD","LU0130102774.USD","LU1066051811.HKD","SG9999014575.USD","LU1430594728.SGD","LU0058720904.USD","LU1585245621.USD","BK4559","LU0289739699.SGD","LU0122379950.USD","BK4588","SG9999002232.USD","IE00BJJMRZ35.SGD","SG9999013999.USD","LU0265550359.USD","LU1699723380.USD","LU1941712264.USD","LU1989772840.SGD","LU1037948541.HKD","LU1093756325.SGD","LU0266013472.USD","LU0980610538.SGD","LU0203347892.USD","IE00BFTCPJ56.SGD","LU1035773651.USD","LU0648001328.SGD","LU2361044865.SGD","IE0002141913.USD","LU1069347547.HKD","IE00BLSP4239.USD","LU1201861249.SGD","LU0965509010.AUD","LU2112291526.USD","LU0320765646.SGD","LU0211331839.USD","LU0965508806.USD","BK4533","LU1929549753.HKD","IE0009355771.USD","LU0965509101.SGD","LU1116320901.HKD","LU2361045086.USD","LU1093756168.USD","LU0098860793.USD","SG9999001440.SGD","LU0320765489.SGD","LU0861579265.USD","IE00B1BXHZ80.USD","LU0130517989.USD","SG9999014567.USD","LU0234572021.USD","SG9999015358.SGD","LU1941712348.USD","LU2023250843.SGD","LU1983299246.USD","LU0238689110.USD","LU1291159041.SGD","LU2468319806.SGD"],"gpt_icon":0},{"id":"1194240832","title":"默沙东启动Kandlelit-007三期临床试验：评估口服KRAS G12C抑制剂Calderasib联合Keytruda Qlex™治疗晚期非小细胞肺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=1194240832","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194240832?lang=zh_cn&edition=full","pubTime":"2026-01-07 19:52","pubTimestamp":1767786737,"startTime":"0","endTime":"0","summary":"默沙东（Merck）近日宣布启动Kandlelit-007三期临床试验，旨在评估其研究性口服KRAS G12C抑制剂Calderasib（代号MK-1084）与Keytruda Qlex™（包含帕博利珠单抗及透明质酸酶阿尔法-PMPH）联合疗法，在特定晚期非小细胞肺癌（NSCLC）患者中的疗效与安全性。\n该试验聚焦于携带KRAS G12C突变的晚期NSCLC患者群体，探索Calderasib与免疫疗法Keytruda Qlex™的协同作用。若研究取得积极结果，有望为这类难治性肺癌患者提供新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1934455277.USD","MRK","IE00BBT3K403.USD","LU1066051225.USD","SGXZ57979304.SGD","LU2089984988.USD","SG9999001176.SGD","SG9999014559.SGD","BK4007","LU1116320737.USD","LU1066051498.USD","IE00B2B36J28.USD","SG9999001176.USD","LU1162221912.USD","LU1023059063.AUD","BK4534","LU0985320562.USD","IE00B4R5TH58.HKD","LU2125154935.USD","IE00BLSP4452.SGD","IE00BN8TJ469.HKD","IE00BSNM7G36.USD","LU1057294990.SGD","LU2361044949.HKD","LU1571399168.USD","BK4550","LU2360032135.SGD","LU1934455194.USD","LU0477156953.USD","LU2125154778.USD","LU0006306889.USD","LU1989772923.USD","IE00BJT1NW94.SGD","LU0070302665.USD","LU1061106388.HKD","LU0106261372.USD","LU1974910355.USD","IE000M9KFDE8.USD","LU1934455863.HKD","LU1917777945.USD","LU2324357040.USD","SG9999015341.SGD","LU0208291251.USD","LU1037948897.HKD","LU0203345920.USD","LU2023250504.SGD","LU1066053197.SGD","SG9999014542.SGD","LU0265550946.USD","LU0965509283.SGD","LU2106854487.HKD","LU1989771016.USD","BK4585","LU2461242641.AUD","BK4516","SG9999002224.SGD","LU0130102774.USD","LU1066051811.HKD","SG9999014575.USD","LU1430594728.SGD","LU0058720904.USD","LU1585245621.USD","BK4559","LU0289739699.SGD","LU0122379950.USD","BK4588","SG9999002232.USD","IE00BJJMRZ35.SGD","SG9999013999.USD","LU0265550359.USD","LU1699723380.USD","LU1941712264.USD","LU1989772840.SGD","LU1037948541.HKD","LU1093756325.SGD","LU0266013472.USD","LU0980610538.SGD","LU0203347892.USD","IE00BFTCPJ56.SGD","LU1035773651.USD","LU0648001328.SGD","LU2361044865.SGD","IE0002141913.USD","LU1069347547.HKD","IE00BLSP4239.USD","LU1201861249.SGD","LU0965509010.AUD","LU2112291526.USD","LU0320765646.SGD","LU0211331839.USD","LU0965508806.USD","BK4533","LU1929549753.HKD","IE0009355771.USD","LU0965509101.SGD","LU1116320901.HKD","LU2361045086.USD","LU1093756168.USD","LU0098860793.USD","SG9999001440.SGD","LU0320765489.SGD","LU0861579265.USD","IE00B1BXHZ80.USD","LU0130517989.USD","SG9999014567.USD","LU0234572021.USD","SG9999015358.SGD","LU1941712348.USD","LU2023250843.SGD","LU1983299246.USD","LU0238689110.USD","LU1291159041.SGD","LU2468319806.SGD"],"gpt_icon":0},{"id":"2601779728","title":"默克公司即将完成对生物制药公司Cidara Therapeutics的收购。","url":"https://stock-news.laohu8.com/highlight/detail?id=2601779728","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601779728?lang=zh_cn&edition=full","pubTime":"2026-01-07 19:47","pubTimestamp":1767786465,"startTime":"0","endTime":"0","summary":null,"market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU1699723380.USD","LU0098860793.USD","LU2089984988.USD","LU0203345920.USD","LU0211331839.USD","LU2125154935.USD","IE00BN8TJ469.HKD","LU1093756168.USD","LU2361044949.HKD","SG9999014542.SGD","SG9999015358.SGD","LU1066051225.USD","SG9999002224.SGD","LU1116320737.USD","IE000M9KFDE8.USD","LU0265550946.USD","BK4585","BK4533","LU1162221912.USD","LU0861579265.USD","LU0006306889.USD","BK4534","LU1941712348.USD","LU0980610538.SGD","LU0130517989.USD","LU1941712264.USD","LU0265550359.USD","LU0070302665.USD","LU1037948897.HKD","LU2361044865.SGD","LU0130102774.USD","BK4139","LU1989772840.SGD","LU2461242641.AUD","SG9999013999.USD","LU0266013472.USD","BK4539","LU1934455277.USD","LU2023250843.SGD","SG9999014559.SGD","BK4559","LU1066051811.HKD","IE00BLSP4239.USD","LU1291159041.SGD","LU0106261372.USD","LU2360032135.SGD","LU2361045086.USD","LU0122379950.USD","LU0965508806.USD","LU1061106388.HKD","BK4007","LU1983299246.USD","MRK","LU0320765646.SGD","LU0289739699.SGD","LU1430594728.SGD","LU2112291526.USD","LU1934455194.USD","BK4550","IE00BSNM7G36.USD","LU1934455863.HKD","SG9999001176.USD","LU1974910355.USD","LU0238689110.USD","LU0234572021.USD","IE00BJJMRZ35.SGD","LU0208291251.USD","SG9999014575.USD","SG9999001440.SGD","CDTX","LU1093756325.SGD","IE00BBT3K403.USD","LU0965509010.AUD","IE00BFTCPJ56.SGD","LU1037948541.HKD","IE00BJT1NW94.SGD","IE00B2B36J28.USD","LU2324357040.USD","SG9999002232.USD","IE0002141913.USD","LU1066053197.SGD","LU0320765489.SGD","LU1066051498.USD","LU1023059063.AUD","LU2468319806.SGD","LU0058720904.USD","LU1201861249.SGD","LU1571399168.USD","LU1585245621.USD","LU1929549753.HKD","LU0965509101.SGD","LU0985320562.USD","IE0009355771.USD","IE00B4R5TH58.HKD","LU0477156953.USD","SGXZ57979304.SGD","IE00B1BXHZ80.USD","LU0965509283.SGD","BK4516","BK4588","LU0203347892.USD","LU1917777945.USD","SG9999001176.SGD","LU2106854487.HKD","IE00BLSP4452.SGD","SG9999014567.USD","LU1116320901.HKD","LU2125154778.USD","LU1989771016.USD","LU0648001328.SGD","LU1989772923.USD","LU2023250504.SGD","SG9999015341.SGD","LU1069347547.HKD","LU1035773651.USD","LU1057294990.SGD"],"gpt_icon":0},{"id":"2601855755","title":"默沙东欣瑞来在华获批；亿帆医药子公司与尚德药缘达成合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2601855755","media":"21世纪经济报道","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601855755?lang=zh_cn&edition=full","pubTime":"2026-01-06 08:00","pubTimestamp":1767657640,"startTime":"0","endTime":"0","summary":"政策动向《医疗服务真实世界医保综合价值评价管理指南（试行）》公开征求意见1月5日，国家医保局发布消息显示，为加快建立全国统一的医疗服务真实世界医保综合价值评价体系，根据《关于开展真实世界医保综合价值评价试点工作的通知》（医保办发〔2025〕15号）有关要求，研究起草了《医疗服务真实世界医保综合价值评价管理指南（试行）》，向社会公开征求意见。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202601063609475182.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601063609475182.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0648001328.SGD","SG9999002224.SGD","LU2112291526.USD","BK4559","LU2089984988.USD","SG9999001176.USD","LU0098860793.USD","LU1571399168.USD","LU0965509101.SGD","LU1989771016.USD","LU0122379950.USD","BK0239","LU0965509010.AUD","LU1917777945.USD","LU1585245621.USD","LU0208291251.USD","BK4534","SG9999001176.SGD","LU1934455194.USD","LU1699723380.USD","LU2468319806.SGD","IE00B2B36J28.USD","LU1941712264.USD","SG9999014575.USD","LU1116320737.USD","LU0861579265.USD","IE00BLSP4452.SGD","LU1093756325.SGD","LU1066051811.HKD","BK0185","LU1035773651.USD","LU1430594728.SGD","IE00BLSP4239.USD","IE0002141913.USD","SGXZ57979304.SGD","LU0980610538.SGD","BK4533","LU2125154935.USD","BK4550","BK4516","LU1066051225.USD","LU1061106388.HKD","SG9999001440.SGD","IE00B1BXHZ80.USD","IE00BBT3K403.USD","LU0265550946.USD","LU1093756168.USD","LU0058720904.USD","IE00BSNM7G36.USD","IE00BJJMRZ35.SGD","BK4585","IE00BN8TJ469.HKD","LU0070302665.USD","LU2023250504.SGD","LU0477156953.USD","SG9999014567.USD","LU0106261372.USD","IE00B4R5TH58.HKD","LU1066053197.SGD","LU0211331839.USD","LU0289739699.SGD","LU2023250843.SGD","BK0191","002019","LU1066051498.USD","LU0965508806.USD","LU1934455863.HKD","LU2324357040.USD","LU1037948541.HKD","LU1023059063.AUD","LU0238689110.USD","LU0130517989.USD","LU1201861249.SGD","IE00BFTCPJ56.SGD","BK4007","SG9999014559.SGD","IE0009355771.USD","LU2360032135.SGD","LU0234572021.USD","LU1934455277.USD","LU0265550359.USD","LU1057294990.SGD","LU0006306889.USD","LU0203345920.USD","LU2361045086.USD","LU1929549753.HKD","BK0070","LU0320765489.SGD","LU0203347892.USD","BK4588","LU1162221912.USD","LU1989772923.USD","LU0320765646.SGD","SG9999014542.SGD","SG9999013999.USD","LU2361044949.HKD","LU0965509283.SGD","SG9999002232.USD","LU1941712348.USD","LU2125154778.USD","BK0197","LU1116320901.HKD","IE00BJT1NW94.SGD","LU2461242641.AUD","LU1291159041.SGD","SG9999015358.SGD","LU2106854487.HKD","LU0985320562.USD","LU1974910355.USD","LU0266013472.USD","MRK","LU1069347547.HKD","LU2361044865.SGD","LU1983299246.USD","LU1989772840.SGD","BK0077","LU1037948897.HKD","SG9999015341.SGD","IE000M9KFDE8.USD","LU0130102774.USD"],"gpt_icon":0},{"id":"1194961366","title":"一周美股牛榜 | 铜价上涨带动麦克莫兰铜金本周累升8%；美光科技上涨7%；花旗周升6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1194961366","media":"老虎资讯综合","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194961366?lang=zh_cn&edition=full","pubTime":"2025-12-29 10:02","pubTimestamp":1766973736,"startTime":"0","endTime":"0","summary":"Qnity Electronics股价上涨约6%$Qnity Electronics$ 本周股价上涨5.7%。Qnity Electronics将季度股息提高了33%，从上季度的每股6美分增至每股8美分。与Groq达成协议提振英伟达股价$英伟达$ 本周股价跃升5.3%。","market":"us","thumbnail":"https://community-static.tradeup.com/news/b709e81a1b4f7405bf5e343b3c9425a7","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/b709e81a1b4f7405bf5e343b3c9425a7"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c8b5e15bc6e8b3cfaf4bdabce2c50e2b","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"一周美股牛榜 | 铜价上涨带动麦克莫兰铜金本周累升8%；美光科技上涨7%；花旗周升6%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNDK","MU","NEM","NUE","NVDA","TPR","MRK","Q","FCX","C"],"gpt_icon":1},{"id":"1156168805","title":"这些“高质量”美股相对大盘折价40%，现在可以行动","url":"https://stock-news.laohu8.com/highlight/detail?id=1156168805","media":"老虎资讯综合","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156168805?lang=zh_cn&edition=full","pubTime":"2025-12-26 16:16","pubTimestamp":1766736968,"startTime":"0","endTime":"0","summary":"瑞银预计 2026 年美股还有约 10% 的上涨空间，但它表示，投资者现在应该转向高质量股票：“在不确定性居高不下、市场拥挤程度极端的情况下，低质量股票的急剧反弹看起来不可持续。”而采用更优方法的投资者，可以找到相对于大盘折价 40% 甚至更多的高质量股票。如果买入质量基金的目的在于对冲核心标普 500 持仓，这样的高度重叠可能并不理想。","market":"us","thumbnail":"https://community-static.tradeup.com/news/12294685851c5acc7bdd837cfdd1ef93","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/12294685851c5acc7bdd837cfdd1ef93"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"d5c389d933a870f6de38533b7589ce70","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COWZ","T","OMC","EXPE","CVX","MRK","GM","DECK","VFLO"],"gpt_icon":1},{"id":"2593546606","title":"同日多家药企新药在华获批上市，自研罕见病创新药引人注目","url":"https://stock-news.laohu8.com/highlight/detail?id=2593546606","media":"动脉网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593546606?lang=zh_cn&edition=full","pubTime":"2025-12-23 09:44","pubTimestamp":1766454240,"startTime":"0","endTime":"0","summary":"2025年药企研发热情和创新活力强劲，12月15日至21日，CDE批准超20款1类创新药临床试验申请，12月22日多家药企新药在华获批上市。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223095030a6c3a87e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223095030a6c3a87e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BZ1G4Q59.USD","LU1093756168.USD","GSK","MRK","BK4532","NVO","BK4599","BK4585","LU0154236417.USD","LU1093756325.SGD","BK4588","BK4007","IE00BKVL7J92.USD"],"gpt_icon":0},{"id":"2592192144","title":"特朗普标榜“大胜”：九大药企达成降价协议换取三年关税豁免","url":"https://stock-news.laohu8.com/highlight/detail?id=2592192144","media":"华尔街见闻","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592192144?lang=zh_cn&edition=full","pubTime":"2025-12-20 08:48","pubTimestamp":1766191729,"startTime":"0","endTime":"0","summary":"默沙东、诺华、葛兰素史克等九家药企签署协议后，特朗普称，今夏被政府盯上的17家药企中已有14家同意“大幅”降价。美商务部长暗示，剩余三家将在年末假期后宣布类似的协议。","market":"sg","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":{"source":null,"url":"https://wallstreetcn.com/articles/3761750","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3761750","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"特朗普标榜“大胜”：九大药企达成降价协议换取三年关税豁免","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRK","GSK","NVS"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.merck.com","stockEarnings":[{"period":"1week","weight":0.0163},{"period":"1month","weight":0.0886},{"period":"3month","weight":0.2891},{"period":"6month","weight":0.3246},{"period":"1year","weight":0.1002},{"period":"ytd","weight":0.0373}],"compareEarnings":[{"period":"1week","weight":0.0108},{"period":"1month","weight":0.0197},{"period":"3month","weight":0.0497},{"period":"6month","weight":0.1136},{"period":"1year","weight":0.1975},{"period":"ytd","weight":0.0194}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"默克制药公司于1970年在新泽西州注册成立。该公司是一家全球医疗保健公司，通过其处方药提供创新的健康解决方案，包括生物疗法、疫苗和动物保健产品。该公司的营运主要以产品为基础进行管理，包括两个经营分部：制药及动物保健国际。","yearOnYearQuotes":[{"month":1,"riseRate":0.565217,"avgChangeRate":0.010129},{"month":2,"riseRate":0.444444,"avgChangeRate":-0.001865},{"month":3,"riseRate":0.622222,"avgChangeRate":-0.002869},{"month":4,"riseRate":0.608696,"avgChangeRate":0.017086},{"month":5,"riseRate":0.630435,"avgChangeRate":0.016179},{"month":6,"riseRate":0.521739,"avgChangeRate":0.013031},{"month":7,"riseRate":0.478261,"avgChangeRate":0.003083},{"month":8,"riseRate":0.5,"avgChangeRate":0.00331},{"month":9,"riseRate":0.521739,"avgChangeRate":-0.006239},{"month":10,"riseRate":0.543478,"avgChangeRate":0.018718},{"month":11,"riseRate":0.717391,"avgChangeRate":0.032717},{"month":12,"riseRate":0.608696,"avgChangeRate":0.013778}],"exchange":"NYSE","name":"默沙东","nameEN":"Merck"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"默沙东(MRK)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供默沙东(MRK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"默沙东,MRK,默沙东股票,默沙东股票老虎,默沙东股票老虎国际,默沙东行情,默沙东股票行情,默沙东股价,默沙东股市,默沙东股票价格,默沙东股票交易,默沙东股票购买,默沙东股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"默沙东(MRK)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供默沙东(MRK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}